ISLAMABAD: The Special Investment Facilitation Council (SIFC) has reviewed plans to expand domestic vaccine manufacturing, regulate prices of critical essential medicines and establish a Pharma Export Council to strengthen Pakistan's pharmaceutical industry and promote exports.

The proposals were discussed during a high-level meeting on November 20, jointly chaired by the Federal Minister for National Health Services, Regulations and Coordination and the National Coordinator of SIFC.

The meeting examined the implementation framework for indigenous vaccine production as part of efforts to reduce reliance on imported vaccines and develop domestic manufacturing capabilities.

Officials also reviewed the proposed mechanism for transparent approval of hardship cases and the fixation of prices for critical essential medicines.

The proposed establishment of a Pharma Export Council was another key agenda item, aimed at supporting the pharmaceutical industry's export potential.

The discussions focused on facilitating investment in pharmaceutical manufacturing, strengthening domestic production and identifying opportunities for industry development.

SIFC reiterated its commitment to promoting self-reliance in vaccine manufacturing and supporting pharmaceutical exports as part of broader efforts to attract investment and contribute to economic growth.